Oren Milstein Ph D
About
Oren Milstein Ph D is from Tampa, Florida, United States. Oren is currently CEO and Chief Scientific Officer at StemRad, Inc, located in Tel Aviv. In Oren's previous role as a Adjunct Faculty at Mount Saint Mary's University, Oren worked in until Jan 2011. Prior to joining Mount Saint Mary's University, Oren was a Postdoctoral Fellow at The Scripps Research Institute and held the position of Postdoctoral Fellow. Prior to that, Oren was a PhD Candidate at The Weizmann Institute of Science from Jan 2002 to Jan 2008. Oren started working as Visiting Scientist at New York University in Jan 2005.
You can find Oren Milstein Ph D's email at finalscout.com. FinalScout is a professional database with business professional profiles and company profiles.
Oren Milstein Ph D's current jobs
StemRad is an Israeli-American company headquartered in Tel Aviv, Israel, that develops, manufactures and sells personal protective equipment (PPE) for ionizing radiation. It is the world's only company producing PPE intended to protect users from high energy ionizing radiation and the first to employ selective shielding in its products. Be it first-responders, military personnel or astronauts, StemRad’s solutions are increasing radiation safety without compromising mission objectives. Groundbreaking science and careful attention to user needs allow StemRad to provide the wearer with the mobility and comfort required to perform critical tasks while remaining safe in the event of exposure to harmful radiation. Comprised of radiation biology experts, nuclear physicists, industrial designers, engineers and backed by world-leading scientists including 3 Nobel Laureates, StemRad provides cutting edge technology to protect our heroes on Earth and beyond!
Oren Milstein Ph D's past jobs
Immunology Lecturer
Subject of research: Host-pathogen interactions; forward genetic analysis of mammalian susceptibility to viral infection
Life Sciences with an emphasis on Cell Biology and Immunology
Immune synapse studies. The role of molecular topology in T cell activation.